Müller R - Search Results

1

Identification of entry inhibitors of Ebola virus pseudotyped vectors from a myxobacterial compound library.

Beck S, Henß L, Weidner T, Herrmann J, Müller R, Chao YK, Grimm C, Weber C, Sliva K, Schnierle BS. Beck S, et al. Among authors: muller r. Antiviral Res. 2016 Aug;132:85-91. doi: 10.1016/j.antiviral.2016.05.017. Epub 2016 May 27. Antiviral Res. 2016. PMID: 27241689

2

Analysis of myxobacterial secondary metabolism goes molecular.

Bode HB, Müller R. Bode HB, et al. Among authors: muller r. J Ind Microbiol Biotechnol. 2006 Jul;33(7):577-88. doi: 10.1007/s10295-006-0082-7. Epub 2006 Feb 21. J Ind Microbiol Biotechnol. 2006. PMID: 16491362 Review.

3

A brief tour of myxobacterial secondary metabolism.

Weissman KJ, Müller R. Weissman KJ, et al. Among authors: muller r. Bioorg Med Chem. 2009 Mar 15;17(6):2121-36. doi: 10.1016/j.bmc.2008.11.025. Epub 2008 Nov 18. Bioorg Med Chem. 2009. PMID: 19109025 Review.

4

Pretubulysin, a potent and chemically accessible tubulysin precursor from Angiococcus disciformis.

Ullrich A, Chai Y, Pistorius D, Elnakady YA, Herrmann JE, Weissman KJ, Kazmaier U, Müller R. Ullrich A, et al. Among authors: muller r. Angew Chem Int Ed Engl. 2009;48(24):4422-5. doi: 10.1002/anie.200900406. Angew Chem Int Ed Engl. 2009. PMID: 19431172

5

Preparation, modification, and evaluation of cruentaren A and analogues.

Bindl M, Jean L, Herrmann J, Müller R, Fürstner A. Bindl M, et al. Among authors: muller r. Chemistry. 2009 Nov 16;15(45):12310-9. doi: 10.1002/chem.200901817. Chemistry. 2009. PMID: 19821471

6

Mining the cinnabaramide biosynthetic pathway to generate novel proteasome inhibitors.

Rachid S, Huo L, Herrmann J, Stadler M, Köpcke B, Bitzer J, Müller R. Rachid S, et al. Among authors: muller r. Chembiochem. 2011 Apr 11;12(6):922-31. doi: 10.1002/cbic.201100024. Epub 2011 Mar 8. Chembiochem. 2011. PMID: 21387511

7

Cytotoxic fatty acid amides from Xenorhabdus.

Proschak A, Schultz K, Herrmann J, Dowling AJ, Brachmann AO, ffrench-Constant R, Müller R, Bode HB. Proschak A, et al. Among authors: muller r. Chembiochem. 2011 Sep 5;12(13):2011-5. doi: 10.1002/cbic.201100223. Epub 2011 Jul 12. Chembiochem. 2011. PMID: 21751325 No abstract available.

8

Anti-angiogenic effects of the tubulysin precursor pretubulysin and of simplified pretubulysin derivatives.

Rath S, Liebl J, Fürst R, Ullrich A, Burkhart JL, Kazmaier U, Herrmann J, Müller R, Günther M, Schreiner L, Wagner E, Vollmar AM, Zahler S. Rath S, et al. Among authors: muller r. Br J Pharmacol. 2012 Nov;167(5):1048-61. doi: 10.1111/j.1476-5381.2012.02037.x. Br J Pharmacol. 2012. PMID: 22595030 Free PMC article.

9

Pretubulysin: from hypothetical biosynthetic intermediate to potential lead in tumor therapy.

Herrmann J, Elnakady YA, Wiedmann RM, Ullrich A, Rohde M, Kazmaier U, Vollmar AM, Müller R. Herrmann J, et al. Among authors: muller r. PLoS One. 2012;7(5):e37416. doi: 10.1371/journal.pone.0037416. Epub 2012 May 17. PLoS One. 2012. PMID: 22616003 Free PMC article.

10

The interplay of lung surfactant proteins and lipids assimilates the macrophage clearance of nanoparticles.

Ruge CA, Schaefer UF, Herrmann J, Kirch J, Cañadas O, Echaide M, Pérez-Gil J, Casals C, Müller R, Lehr CM. Ruge CA, et al. Among authors: muller r. PLoS One. 2012;7(7):e40775. doi: 10.1371/journal.pone.0040775. Epub 2012 Jul 10. PLoS One. 2012. PMID: 22802970 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,382 results

Search Page